vs
FLUSHING FINANCIAL CORP（FFIC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是FLUSHING FINANCIAL CORP的1.2倍（$69.8M vs $58.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 6.8%，领先377.2%），FLUSHING FINANCIAL CORP同比增速更快（2597.7% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.7%）
弗拉格斯塔夫银行（Flagstar Bank, N.A.）是美国区域性金融服务控股集团，总部位于纽约希克斯维尔。2023年该行共运营395家分支机构，并于2024年2月21日完成全部分支机构的品牌统一，全部更名为Flagstar品牌。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FFIC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$58.8M
营收增速更快
FFIC
高出2576.5%
21.2%
净利率更高
RIGL
高出377.2%
6.8%
两年增速更快
RIGL
近两年复合增速
13.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.8M | $69.8M |
| 净利润 | $4.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 13.3% | 33.2% |
| 净利率 | 6.8% | 384.0% |
| 营收同比 | 2597.7% | 21.2% |
| 净利润同比 | 108.2% | 1769.2% |
| 每股收益（稀释后） | $0.12 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FFICRIGL
| Q4 25 | $58.8M | $69.8M | ||
| Q3 25 | $58.6M | $69.5M | ||
| Q2 25 | $63.5M | $101.7M | ||
| Q1 25 | $58.1M | $53.3M | ||
| Q4 24 | $2.2M | $57.6M | ||
| Q3 24 | $51.9M | $55.3M | ||
| Q2 24 | $47.0M | $36.8M | ||
| Q1 24 | $45.5M | $29.5M |
净利润FFICRIGL
| Q4 25 | $4.0M | $268.1M | ||
| Q3 25 | $10.4M | $27.9M | ||
| Q2 25 | $14.2M | $59.6M | ||
| Q1 25 | $-9.8M | $11.4M | ||
| Q4 24 | $-49.2M | $14.3M | ||
| Q3 24 | $8.9M | $12.4M | ||
| Q2 24 | $5.3M | $-1.0M | ||
| Q1 24 | $3.7M | $-8.2M |
毛利率FFICRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FFICRIGL
| Q4 25 | 13.3% | 33.2% | ||
| Q3 25 | 23.4% | 40.9% | ||
| Q2 25 | 29.8% | 60.1% | ||
| Q1 25 | -10.2% | 23.9% | ||
| Q4 24 | -3296.2% | 28.9% | ||
| Q3 24 | 22.1% | 25.4% | ||
| Q2 24 | 15.2% | 1.2% | ||
| Q1 24 | 11.0% | -23.6% |
净利率FFICRIGL
| Q4 25 | 6.8% | 384.0% | ||
| Q3 25 | 17.8% | 40.2% | ||
| Q2 25 | 22.4% | 58.6% | ||
| Q1 25 | -16.9% | 21.5% | ||
| Q4 24 | -2258.9% | 24.9% | ||
| Q3 24 | 17.2% | 22.5% | ||
| Q2 24 | 11.3% | -2.8% | ||
| Q1 24 | 8.1% | -27.9% |
每股收益（稀释后）FFICRIGL
| Q4 25 | $0.12 | $14.11 | ||
| Q3 25 | $0.30 | $1.46 | ||
| Q2 25 | $0.41 | $3.28 | ||
| Q1 25 | $-0.29 | $0.63 | ||
| Q4 24 | $-1.67 | $0.82 | ||
| Q3 24 | $0.30 | $0.70 | ||
| Q2 24 | $0.18 | $-0.06 | ||
| Q1 24 | $0.12 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $708.0M | $391.5M |
| 总资产 | $8.7B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FFICRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务FFICRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益FFICRIGL
| Q4 25 | $708.0M | $391.5M | ||
| Q3 25 | $711.2M | $117.6M | ||
| Q2 25 | $706.4M | $81.9M | ||
| Q1 25 | $702.9M | $18.6M | ||
| Q4 24 | $724.5M | $3.3M | ||
| Q3 24 | $666.9M | $-14.6M | ||
| Q2 24 | $665.3M | $-29.9M | ||
| Q1 24 | $669.8M | $-31.7M |
总资产FFICRIGL
| Q4 25 | $8.7B | $513.6M | ||
| Q3 25 | $8.9B | $242.5M | ||
| Q2 25 | $8.8B | $206.7M | ||
| Q1 25 | $9.0B | $176.0M | ||
| Q4 24 | $9.0B | $164.0M | ||
| Q3 24 | $9.3B | $139.4M | ||
| Q2 24 | $9.1B | $128.4M | ||
| Q1 24 | $8.8B | $126.5M |
负债/权益比FFICRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | — |
| 自由现金流率自由现金流/营收 | 94.9% | — |
| 资本支出强度资本支出/营收 | 8.9% | — |
| 现金转化率经营现金流/净利润 | 15.16× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $104.7M | — |
8季度趋势，按日历期对齐
经营现金流FFICRIGL
| Q4 25 | $61.0M | $22.0M | ||
| Q3 25 | $19.6M | $24.0M | ||
| Q2 25 | $25.8M | $30.5M | ||
| Q1 25 | $6.9M | $-893.0K | ||
| Q4 24 | $12.4M | $14.5M | ||
| Q3 24 | $5.4M | $21.7M | ||
| Q2 24 | $9.6M | $302.0K | ||
| Q1 24 | $-6.2M | $-5.0M |
自由现金流FFICRIGL
| Q4 25 | $55.8M | — | ||
| Q3 25 | $19.3M | — | ||
| Q2 25 | $24.4M | — | ||
| Q1 25 | $5.2M | — | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $8.8M | — | ||
| Q1 24 | $-6.5M | — |
自由现金流率FFICRIGL
| Q4 25 | 94.9% | — | ||
| Q3 25 | 33.0% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 463.4% | — | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | -14.3% | — |
资本支出强度FFICRIGL
| Q4 25 | 8.9% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 106.0% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 0.6% | — |
现金转化率FFICRIGL
| Q4 25 | 15.16× | 0.08× | ||
| Q3 25 | 1.87× | 0.86× | ||
| Q2 25 | 1.81× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 0.61× | 1.75× | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -1.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
